Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
New Molecule Has the Potential of Stopping or Slowing Parkinson’s
BioSpace
Mon, 02/17/20 - 10:23 am
Parkinson's Disease
BT13
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Fri, 02/14/20 - 10:35 am
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
Gut link to Parkinson's sparks talk of probiotic treatment strategy
Fierce Biotech
Tue, 01/14/20 - 09:46 pm
Parkinson's Disease
probiotics
microbiome
How Novartis' cancer drug Tasigna restores critical dopamine that's lost to Parkinson's disease
Fierce Biotech
Tue, 12/17/19 - 10:26 am
Tasigna
Novartis
Parkinson's Disease
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
Xconomy
Thu, 12/12/19 - 10:59 am
Aspen Neuro
Parkinson's Disease
stem cell therapy
RightEye Has “Breakthrough” in Its Vision for Parkinson’s Test
Medical Devices and Diagnostics Industry
Tue, 12/3/19 - 10:25 pm
RightEye
RightEye Vision System
diagnostics
Parkinson's Disease
Japan's Kyowa Kirin reorganizes quality responsibilities
Fierce Pharma
Wed, 11/27/19 - 10:44 am
Japan
Kyowa Hakko Kirin
Parkinson's Disease
pharmacovigilance
Quality Assurance
Nourianz
Cerevel plots first late-stage move as Pfizer drug comes through in PhII Parkinson's trial
Endpoints
Tue, 09/24/19 - 11:08 am
Cerevel Therapeutics
Pfizer
clinical trials
Parkinson's Disease
tavapadon
Prostate drug may slow Parkinson’s progression, big data suggests
Fierce Biotech
Mon, 09/16/19 - 05:11 pm
terazosin
Parkinson's Disease
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
Pharmaceutical Business Review
Wed, 08/28/19 - 10:46 am
Nourianz
Parkinson's Disease
FDA
Kyowa Hakko Kirin
D&D bags $137M to fund midphase Alzheimer's, Parkinson's trials
Fierce Biotech
Wed, 08/14/19 - 11:03 am
D&D Pharmatech
neurodegenerative disease
Alzheimer's disease
Parkinson's Disease
Intec blitzed by PhIII flop as lead program fails to beat Merck's standard combo for Parkinson’s
Endpoints
Mon, 07/22/19 - 09:41 am
Intec Pharma
Parkinson's Disease
clinical trials
Accordion Pill-Carbidopa/Levodopa
FDA Accepts Neurocrine's NDA for Parkinson's Disease Drug
Yahoo/Zacks.com
Fri, 07/12/19 - 09:45 am
Neurocrine Biosciences
FDA
Parkinson's Disease
opicapone
New evidence of a link between Parkinson's disease and the gut could inspire treatments
Fierce Biotech
Wed, 06/26/19 - 11:47 pm
Parkinson's Disease
Johns Hopkins
protein folding
Abbott and NIH Join Forces to Advance Neuroscience Research
Medical Devices and Diagnostics Industry
Wed, 05/15/19 - 10:34 am
Abbott Labs
NIH
devices
chronic pain
R&D
Parkinson's Disease
Tencent Starts Collecting Medical Data On U.K. Patients In Parkinson's Trial
Forbes
Tue, 05/7/19 - 10:08 am
Tencent
clinical trials
Parkinson's Disease
Medopad
artificial intelligence
Neurocrine’s Opicapone Plus Levodopa Improves Parkinson’s Symptoms
BioSpace
Mon, 05/6/19 - 10:59 am
Neurocrine Biosciences
clinical trials
opicapone
Parkinson's Disease
Inflazome grabs Fox Foundation funding for Parkinson’s R&D
Fierce Biotech
Mon, 03/25/19 - 10:26 am
Inflazome
Parkinson's Disease
R&D
Servier and Oncodesign announce Parkinson’s R&D tie-up
Pharmaforum
Wed, 03/13/19 - 11:18 pm
Servier
Oncodesign
R&D
Parkinson's Disease
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »